ロード中...
Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor Agonists
Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease characterized by the progressive destruction of the intrahepatic bile ducts. Currently, the first line drug for PBC is ursodeoxycholic acid (UDCA) characterized by anti-apoptotic, anti-inflammatory and protective actions on chol...
保存先:
| 出版年: | Diseases |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7348889/ https://ncbi.nlm.nih.gov/pubmed/32532037 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diseases8020020 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|